Hundreds contact BBC about mystery skin condition ‘hell’ – but doctors can’t agree it exists
Hundreds contact BBC about mystery skin condition ‘hell’ – but doctors can’t agree it exists
The Mystery of TSW
Two weeks ago, I penned a BBC News piece examining the growing concern surrounding a severe skin condition, topical steroid withdrawal (TSW), which has sparked widespread discussion online. Some view it as an intense form of eczema, while others argue it is a distinct affliction. Yet, the medical community remains divided on its classification. The article resonated strongly, drawing millions of readers and prompting 240 messages from individuals affected by the condition. What has led to such a surge in interest?
Bethany’s Fight
At a hospital with her arms bandaged, Bethany Norman clung to her newborn son, refusing to apply steroid creams despite doctors’ recommendations. She recalled shouting, “Look at what this medication has done to me? Why would I risk it on my own child?” Her belief was that the creams she’d used for lifelong eczema management had triggered TSW. Her symptoms included open wounds, an unrelenting itch, and constant skin flaking. “I felt trapped in my own body,” she said, vowing to avoid similar suffering for her baby.
Doctors’ Dilemma
Topical steroids have been a staple in eczema treatment since the 1950s, offering relief to countless patients. These range from mild over-the-counter options like hydrocortisone to prescription-strength formulations. However, a growing number of patients claim these creams are no longer effective for them, leading to frustration and distrust. The Medicines and Healthcare products Regulatory Agency (MHRA) acknowledged TSW as a possible reaction to prolonged steroid use in 2021, but it hasn’t been formally classified as a distinct condition.
Breaking the Silence
Jenna Crosbie, a trainee GP in north Wales, initially found it puzzling when a patient declined steroid treatment. “I couldn’t grasp why they would refuse something we’ve long relied on,” she said. Yet, after her own eczema symptoms shifted—redness spreading despite increased steroid use—she began to understand. “I wouldn’t wish this experience on my worst enemy,” she remarked, reflecting on her A&E encounter. Her GP’s support helped her navigate the change, bridging the gap between patient and physician.
The Prescription Paradox
Dr. Dean Eggit, a Doncaster-based GP, noted that steroids are essential but can sometimes be misapplied. “We often see a red rash and reach for a steroid cream without investigating further,” he explained. This approach might inadvertently worsen TSW, as initial symptoms can resemble eczema. “It’s a risk we may not fully recognize,” he added, highlighting the complexity of diagnosing the condition.
Guidelines in Question
The National Institute for Health and Clinical Excellence (NICE) advocates for a step-wise treatment strategy, starting with emollients and gradually adjusting steroid potency. Yet, Dr. Adrian Hayter from the Royal College of GPs emphasized the need for follow-ups on repeat prescriptions. “If a patient is using steroids regularly, we must ensure their treatment is still appropriate,” he said, underscoring the ongoing debate about how best to manage TSW in clinical settings.
